Laboratorio Reig Jofre (XMAD:RJF) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Laboratorio Reig Jofre's Free Cash Flow for the three months ended in Dec. 2023 was €0.0 Mil. Laboratorio Reig Jofre's Revenue for the three months ended in Dec. 2023 was €78.8 Mil. Therefore, Laboratorio Reig Jofre's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Laboratorio Reig Jofre's current FCF Yield % is 3.12%.

The historical rank and industry rank for Laboratorio Reig Jofre's FCF Margin % or its related term are showing as below:

XMAD:RJF' s FCF Margin % Range Over the Past 10 Years
Min: -32.41 Med: -0.35 Max: 3.99
Current: 3.99

During the past 13 years, the highest FCF Margin % of Laboratorio Reig Jofre was 3.99%. The lowest was -32.41%. And the median was -0.35%.

XMAD:RJF's FCF Margin % is ranked better than
63.06% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs XMAD:RJF: 3.99

Laboratorio Reig Jofre FCF Margin % Historical Data

The historical data trend for Laboratorio Reig Jofre's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre FCF Margin % Chart

Laboratorio Reig Jofre Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-9.72

2.85

-2.23

1.75

2.01

Laboratorio Reig Jofre Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Laboratorio Reig Jofre's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorio Reig Jofre's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's FCF Margin % falls into.

Laboratorio Reig Jofre FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Laboratorio Reig Jofre's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	6.345	/	316.088
	=	2.01 %

Laboratorio Reig Jofre's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	78.806
	=	0.00 %

Laboratorio Reig Jofre FCF Margin % Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Reig Jofre (XMAD:RJF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

FEQ1:Germany

Address

Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970

Website

http://www.reigjofre.com

Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.